Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

Similar articles for PubMed (Select 20843240)

1.

The safety of tiotropium--the FDA's conclusions.

Michele TM, Pinheiro S, Iyasu S.

N Engl J Med. 2010 Sep 16;363(12):1097-9. doi: 10.1056/NEJMp1008502. Epub 2010 Sep 8. No abstract available.

2.

Tiotropium in chronic obstructive pulmonary disease.

Sierra-Sánchez JF Sr, Alegre-del Rey EJ Sr, Cobo I Sr.

N Engl J Med. 2009 Jan 8;360(2):186-7; author reply 187. No abstract available.

PMID:
19137625
3.

Tiotropium: a potential replacement for ipratropium in patients with COPD.

Shukla VK.

Issues Emerg Health Technol. 2002 Jul;(35):1-4.

PMID:
12195603
4.

Tiotropium Respimat increases the risk of mortality.

Jenkins CR, Beasley R.

Thorax. 2013 Jan;68(1):5-7. doi: 10.1136/thoraxjnl-2012-202482. No abstract available. Erratum in: Thorax. 2013 Feb;68(2):162.

PMID:
23229813
5.

Tiotropium versus salmeterol in COPD.

Oba Y.

N Engl J Med. 2011 Jun 30;364(26):2553; author reply 2553-4. doi: 10.1056/NEJMc1104617#SA4. No abstract available.

PMID:
21714654
6.
7.

The efficacy and safety of tiotropium in Chinese patients with stable chronic obstructive pulmonary disease: a meta-analysis.

Wu Q, Li G, Lei WI, Zhou X.

Respirology. 2009 Jul;14(5):666-74. doi: 10.1111/j.1440-1843.2009.01525.x. Epub 2009 Apr 8.

PMID:
19402836
8.

Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.

Somand H, Remington TL.

Ann Pharmacother. 2005 Sep;39(9):1467-75. Epub 2005 Jul 19. Review.

PMID:
16030078
9.

The cardiovascular risk of tiotropium: is it real?

Cazzola M, Calzetta L, Matera MG.

Expert Opin Drug Saf. 2010 Sep;9(5):783-92. doi: 10.1517/14740338.2010.500611. Review.

PMID:
20565229
10.

Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.

ZuWallack AR, ZuWallack RL.

Expert Opin Pharmacother. 2004 Aug;5(8):1827-35. Review. Erratum in: Expert Opin Pharmacother. 2004 Sep;5(9):2051.

PMID:
15264997
11.

[Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)].

Osztovits J, Fehér J.

Orv Hetil. 2010 May 2;151(18):749-50. doi: 10.1556/OH.2010.28883. Hungarian. No abstract available.

PMID:
20410002
12.

Tiotropium in chronic obstructive pulmonary disease.

Singh S, Furberg CD, Loke YK.

N Engl J Med. 2009 Jan 8;360(2):186; author reply 187. No abstract available.

PMID:
19137626
13.

Tiotropium-lessons from recent studies.

Black PN.

Respirology. 2009 Jul;14(5):623-4. doi: 10.1111/j.1440-1843.2009.01544.x. No abstract available.

PMID:
19659644
14.

Tiotropium for chronic obstructive pulmonary disease.

[No authors listed]

Drug Ther Bull. 2003 Feb;41(2):15-6. Review.

PMID:
12630336
15.

Pooled clinical trial analysis of tiotropium safety.

Kesten S, Jara M, Wentworth C, Lanes S.

Chest. 2006 Dec;130(6):1695-703.

PMID:
17166984
16.
17.

Safety of tiotropium.

Cates CJ.

BMJ. 2011 Jun 14;342:d2970. doi: 10.1136/bmj.d2970. No abstract available.

PMID:
21672998
18.

Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.

Salpeter SR.

Drugs. 2009 Oct 22;69(15):2025-33. doi: 10.2165/11318580-000000000-00000.

PMID:
19791824
19.

Tiotropium: stroke. Do not use this drug.

[No authors listed]

Prescrire Int. 2009 Apr;18(100):68. No abstract available.

PMID:
19588553
20.

Tiotropium Respimat increases the risk of mortality: pro.

Beasley R.

Eur Respir J. 2013 Sep;42(3):584-9. doi: 10.1183/09031936.00042113. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk